The first UK research study into the medical benefits of cannabis on Multiple Scelrosis has shown there is no benefit.
However there were benefits for those at the lower end of the disability scale.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study was carried out by researchers from the Peninsula College of Medicine and Dentistry.
It enrolled nearly 500 people with MS from 27 centres around the UK, who were either given capsules containing the active ingredient of cannabis and some given a placebo.
Alison Smith, an MS sufferer took part in the trial:
More top news
Britons wounded in Friday's terror attack in Sousse have been brought back to the UK by the RAF.
A woman who photographed a touching proposal on top of the Eiffel Tower has taken to social media to track down the couple.
Prisoners at a correctional facility in Melbourne are rioting over a smoking ban due to take effect today.